Medpace Holdings, Inc.
MEDPNasdaqIndustrials · Services-Commercial Physical & Biological Research · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $2.53B | $2.11B | $1.89B | $1.46B | $1.14B | $925.9M |
| Operating income | $534.9M | $446.9M | $336.8M | $278.7M | $198.6M | $167.0M |
| Net income | $451.1M | $404.4M | $282.8M | $245.4M | $181.8M | $145.4M |
| Total assets | $1.98B | $2.10B | $1.66B | $1.35B | $1.66B | $1.39B |
| Total liabilities | $1.52B | $1.28B | $1.10B | $966.1M | $707.0M | $584.9M |
| Equity | $459.1M | $825.5M | $559.0M | $386.4M | $952.9M | $805.8M |
| EPS (diluted) | $15.28 | $12.63 | $8.88 | $7.28 | $4.81 | $3.84 |
| Shares out. | 30.5M | 30.8M | 31.1M | 35.2M | 35.7M | 36.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 21.1%
- Net margin
- 17.8%
- Return on equity
- 98.3%
- Return on assets
- 22.8%
- Return on capital (ROCE)
- 84.7%
- Liabilities / assets
- 76.8%
- Debt / equity
- 3.30×
- Book value / share
- $15.07
- Revenue growth (YoY)
- 20.0%
- Net income growth (YoY)
- 11.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 0.20distress
- Accruals / assets
- −13.3%clean
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 1 warning● 5 good- Altman Z″ in the distress zone
- High leverage (liabilities > 70% of assets)
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Group IncPassive (13G)Mar 27, 2026
- Troendle August J.Activist (13D)Dec 1, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1.9M | 5.5 | +22.8% |
| Apr 30, 2026 | 1.6M | 2.5 | +15.1% |
| Apr 15, 2026 | 1.3M | 4.1 | +10.5% |
| Mar 31, 2026 | 1.2M | 4.1 | -12.9% |
| Mar 13, 2026 | 1.4M | 4.4 | +9.2% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Amended charter or bylaws · Shareholder voteMay 19, 2026
- Results of operations · Director / officer changeApr 22, 2026
- Results of operationsFeb 9, 2026
- Results of operationsOct 22, 2025
- Entered a material agreement · Results of operationsJul 21, 2025
- Director / officer change · Shareholder voteMay 16, 2025
- Entered a material agreement · Results of operations · Other material eventApr 21, 2025
- Entered a material agreementMar 31, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.